Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

254 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Crohn's disease: beyond antagonists of tumour necrosis factor.
Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF. Peyrin-Biroulet L, et al. Among authors: desreumaux p. Lancet. 2008 Jul 5;372(9632):67-81. doi: 10.1016/S0140-6736(08)60995-2. Lancet. 2008. PMID: 18603161 Review.
[New inflammatory bowel disease drugs targeting the inflammatory cascade].
Desreumaux P. Desreumaux P. Gastroenterol Clin Biol. 2001 Apr;25(4 Suppl):B72-8. Gastroenterol Clin Biol. 2001. PMID: 11449147 Review. French. No abstract available.
[Role of antibiotics in Crohn's disease].
Bulois P, Lederman E, Desreumaux P, Cortot A, Colombel JF. Bulois P, et al. Among authors: desreumaux p. Gastroenterol Clin Biol. 1999 Jun;23(5 Pt 2):B189-94. Gastroenterol Clin Biol. 1999. PMID: 10897791 Review. French. No abstract available.
Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions.
Duburque C, Lelong J, Iacob R, Seddik M, Desreumaux P, Fournier C, Wallaert B, Cortot A, Colombel JF. Duburque C, et al. Among authors: desreumaux p. Aliment Pharmacol Ther. 2006 Sep 1;24(5):851-8. doi: 10.1111/j.1365-2036.2006.03026.x. Aliment Pharmacol Ther. 2006. PMID: 16918890
Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases.
Guidat A, Fleyfel M, Vallet B, Desreumaux P, Levron JC, Gambiez L, Colombel JF, Scherpereel P. Guidat A, et al. Among authors: desreumaux p. Eur J Anaesthesiol. 2003 Dec;20(12):957-62. doi: 10.1017/s0265021503001546. Eur J Anaesthesiol. 2003. PMID: 14690097 Clinical Trial.
Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.
Philippe D, Chakass D, Thuru X, Zerbib P, Tsicopoulos A, Geboes K, Bulois P, Breisse M, Vorng H, Gay J, Colombel JF, Desreumaux P, Chamaillard M. Philippe D, et al. Among authors: desreumaux p. Gut. 2006 Jun;55(6):815-23. doi: 10.1136/gut.2005.080887. Epub 2005 Nov 18. Gut. 2006. PMID: 16299031 Free PMC article.
Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease.
Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C, Saudemont A, Tachon M, B├ęclin E, Odou MF, Neut C, Colombel JF, Desreumaux P. Peyrin-Biroulet L, et al. Among authors: desreumaux p. Gut. 2012 Jan;61(1):78-85. doi: 10.1136/gutjnl-2011-300370. Epub 2011 Sep 21. Gut. 2012. PMID: 21940721 Free PMC article.
Advances and perspectives in the genetics of inflammatory bowel diseases.
Chamaillard M, Iacob R, Desreumaux P, Colombel JF. Chamaillard M, et al. Among authors: desreumaux p. Clin Gastroenterol Hepatol. 2006 Feb;4(2):143-51. doi: 10.1016/j.cgh.2005.11.008. Clin Gastroenterol Hepatol. 2006. PMID: 16469672 Review.
Treatments for Crohn's Disease-Associated Bowel Damage: A Systematic Review.
Pariente B, Hu S, Bettenworth D, Speca S, Desreumaux P, Meuwis MA, Danese S, Rieder F, Louis E. Pariente B, et al. Among authors: desreumaux p. Clin Gastroenterol Hepatol. 2019 Apr;17(5):847-856. doi: 10.1016/j.cgh.2018.06.043. Epub 2018 Aug 23. Clin Gastroenterol Hepatol. 2019. PMID: 30012430
Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumab.
Duveau N, Nachury M, Gerard R, Branche J, Maunoury V, Boualit M, Wils P, Desreumaux P, Pariente B. Duveau N, et al. Among authors: desreumaux p. Dig Liver Dis. 2017 Feb;49(2):163-169. doi: 10.1016/j.dld.2016.11.002. Epub 2016 Nov 14. Dig Liver Dis. 2017. PMID: 27899263
254 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback